Cargando…

APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target

Background: The pathogenesis of hepatocellular carcinoma (HCC) is a multistep process contributed by the accumulation of molecular alterations. We identified Apelin (APLN) as an outlier gene up-regulated in hepatocellular carcinoma (HCC) through RNA-Seq and microarray analysis. We aimed to investiga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Huarong, Wong, Chi-Chun, Liu, Dabin, Go, Minnie Y.Y., Wu, Bin, Peng, Sui, Kuang, Ming, Wong, Nathalie, Yu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691573/ https://www.ncbi.nlm.nih.gov/pubmed/31410213 http://dx.doi.org/10.7150/thno.34713

Ejemplares similares

Emerging roles of APLN and APELA in the physiology and pathology of the female reproductive system
por: Wang, Xueying, et al.
Publicado: (2020)

APLN: A potential novel biomarker for cervical cancer
por: Chen, Yusha, et al.
Publicado: (2021)

Genetic targeting of sprouting angiogenesis using Apln-CreER
por: Liu, Qiaozhen, et al.
Publicado: (2015)

Relationships of apelin concentration and APLN T-1860C polymorphism with obesity in Thai children
por: Suriyaprom, Kanjana, et al.
Publicado: (2020)

microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway
por: Wang, Jia, et al.
Publicado: (2014)

APLN/APLNR Signaling Controls Key Pathological Parameters of Glioblastoma
por: Kälin, Roland E., et al.
Publicado: (2021)

High APLN Expression Predicts Poor Prognosis for Glioma Patients
por: Lv, Shuangyu, et al.
Publicado: (2022)

Associations of Common Variants at APLN and Hypertension in Chinese Subjects with and without Diabetes
por: Zhang, Rong, et al.
Publicado: (2012)

Inhibition of APLN suppresses cell proliferation and migration and promotes cell apoptosis in esophageal cancer cells in vitro, through activating PI3K/mTOR signaling pathway
por: Wang, Yuhan, et al.
Publicado: (2022)

Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma
por: Liao, Junbin, et al.
Publicado: (2019)

Apln-CreERT:mT/mG reporter mice as a tool for sprouting angiogenesis study
por: Pi, Jingjiang, et al.
Publicado: (2017)

Targeting APLN/APJ restores blood-testis barrier and improves spermatogenesis in murine and human diabetic models
por: Song, Ke, et al.
Publicado: (2022)

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
por: Sun, Eun Jin, et al.
Publicado: (2021)

NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling
por: Gong, Chengwu, et al.
Publicado: (2019)

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
por: Huang, Lu, et al.
Publicado: (2022)

The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
por: Tian, Ling-Yu, et al.
Publicado: (2023)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
por: Bang, Jieun, et al.
Publicado: (2023)

Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
por: Zhang, P-F, et al.
Publicado: (2016)

Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular Carcinoma
por: Xia, Zhong-Kun, et al.
Publicado: (2021)

ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
por: Ni, Sheng, et al.
Publicado: (2020)

Aberrant expression of PI3K/AKT signaling is involved in apoptosis resistance of hepatocellular carcinoma
por: Wang, Zhuangqiang, et al.
Publicado: (2021)

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
por: Huang, Lu, et al.
Publicado: (2022)

PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis
por: Mercurio, Laura, et al.
Publicado: (2021)

HLA-B*27 Heavy Chain Homo-Oligomers Promote the Cytotoxicity of NK Cells via Activation of PI3K/AKT Signaling
por: Yu, Hui-Chun, et al.
Publicado: (2022)

Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin
por: Ou, Da-Liang, et al.
Publicado: (2014)

Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71
por: Wong, Wen-Rou, et al.
Publicado: (2005)

TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
por: Ye, Yanqing, et al.
Publicado: (2023)

Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma
por: Wang, Houhong, et al.
Publicado: (2023)

Pre-mRNA Processing Factor 8 Accelerates the Progression of Hepatocellular Carcinoma by Regulating the PI3K/Akt Pathway
por: Wang, Shouhan, et al.
Publicado: (2020)

Mechanisms of resistance to a PI3K inhibitor in gastrointestinal stromal tumors: an omic approach to identify novel druggable targets
por: Ravegnini, Gloria, et al.
Publicado: (2019)

CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer
por: Gao, Shanshan, et al.
Publicado: (2021)

ISL Induces Apoptosis and Autophagy in Hepatocellular Carcinoma via Downregulation of PI3K/AKT/mTOR Pathway in vivo and in vitro
por: Song, Lei, et al.
Publicado: (2020)

PI3Kα inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma
por: Xie, Qin, et al.
Publicado: (2021)

Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway
por: Hsieh, Yi-Hsien, et al.
Publicado: (2015)

Getting the Akt Together: Guiding Intracellular Akt Activity by PI3K
por: Yudushkin, Ivan
Publicado: (2019)

HijAkt: The PI3K/Akt Pathway in Virus Replication and Pathogenesis
por: Dunn, Ewan F., et al.
Publicado: (2012)

Targeting PI3K/Akt signal transduction for cancer therapy
por: He, Yan, et al.
Publicado: (2021)

PI3K/AKT Pathway and Brain Malformations
por: Rice, Gavin B., et al.
Publicado: (2015)

PI3K and AKT: Unfaithful Partners in Cancer
por: Faes, Seraina, et al.
Publicado: (2015)

The PI3K/Akt Pathway in Meta-Inflammation
por: Acosta-Martinez, Maricedes, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fc6ekfp4fb34gp24f370huukus